{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T07:17:54Z","timestamp":1761895074240,"version":"build-2065373602"},"reference-count":38,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2010,6,1]],"date-time":"2010-06-01T00:00:00Z","timestamp":1275350400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,6,1]],"date-time":"2010-06-01T00:00:00Z","timestamp":1275350400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinicaloncologyonline.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Oncology"],"published-print":{"date-parts":[[2010,6]]},"DOI":"10.1016\/j.clon.2010.03.007","type":"journal-article","created":{"date-parts":[[2010,4,28]],"date-time":"2010-04-28T09:12:46Z","timestamp":1272445966000},"page":"347-355","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":36,"title":["Is Concurrent Chemoradiation the Standard of Care for Locally Advanced Non-small Cell Lung Cancer? A Review of Guidelines and Evidence"],"prefix":"10.1016","volume":"22","author":[{"given":"N.","family":"O'Rourke","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Macbeth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clon.2010.03.007_bib1","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/S1470-2045(01)00486-7","article-title":"Global cancer statistics in the year 2000","volume":"2","author":"Parkin","year":"2001","journal-title":"Lancet Oncol"},{"issue":"9","key":"10.1016\/j.clon.2010.03.007_bib2","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/S1470-2045(07)70246-2","article-title":"Recent cancer survival in Europe: a 2000\u20132002 analysis of EUROCARE-4 data","volume":"8","author":"Verdecchia","year":"2007","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.clon.2010.03.007_bib3","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1200\/JCO.1990.8.9.1543","article-title":"A randomized phase I\/II trial of hyperfractionated radiation therapy with total doses of 60 to 79.2 Gy: possible survival benefit with greater than or equal to 69.6 Gy in favourable patients with RTOG stage III NSCLC: report of RTOG 83-11","volume":"8","author":"Cox","year":"1990","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clon.2010.03.007_bib4","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0167-8140(99)00087-0","article-title":"Continuous hyperfractionated accelerated radiotherapy (CHART) versus conventional radiotherapy in non-small cell lung cancer: mature data from the randomised multicentre trial","volume":"52","author":"Saunders","year":"1999","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.clon.2010.03.007_bib5","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1136\/bmj.311.7010.899","article-title":"Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomised clinical trials","volume":"311","year":"1995","journal-title":"Br Med J"},{"key":"10.1016\/j.clon.2010.03.007_bib6","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1093\/annonc\/mdj117","article-title":"Concomitant radio-chemotherapy based on platin compounds in patients with locally advanced NSCLC: a meta-analysis of individual data from 1764 patients","volume":"17","author":"Auperin","year":"2006","journal-title":"Ann Oncol"},{"key":"10.1016\/j.clon.2010.03.007_bib7","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD002140.pub2","article-title":"Concurrent chemoradiotherapy in non-small cell lung cancer","volume":"4","author":"Rowell","year":"2004","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.clon.2010.03.007_bib8","first-page":"330","article-title":"Clinical practice guidelines for the treatment of unresectable non-small cell lung cancer","volume":"22","author":"American Society of Clinical Oncology","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clon.2010.03.007_bib9","doi-asserted-by":"crossref","first-page":"2692","DOI":"10.1200\/JCO.1999.17.9.2692","article-title":"Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine and cisplatin in unresectable stage III non-small cell lung cancer","volume":"17","author":"Furuse","year":"1999","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clon.2010.03.007_bib10","first-page":"621","article-title":"Long-term benefit is observed in a phase III comparison of sequential vs concurrent chemoradiation for patients with unresected stage III NSCLC: RTOG 9410 (abstract)","volume":"22","author":"Curran","year":"2003","journal-title":"Proc Am Soc Oncol"},{"key":"10.1016\/j.clon.2010.03.007_bib11","doi-asserted-by":"crossref","first-page":"S47","DOI":"10.1016\/j.lungcan.2003.08.011","article-title":"Combined modality therapy for unresectable non-small cell lung cancer","volume":"42","author":"IASLC Workshop","year":"2003","journal-title":"Lung Cancer"},{"key":"10.1016\/j.clon.2010.03.007_bib12","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/S1556-0864(15)31598-7","article-title":"Management of unresected stage III non-small cell lung cancer: a systematic review","volume":"1","author":"Okawara","year":"2006","journal-title":"J Thor Oncol"},{"key":"10.1016\/j.clon.2010.03.007_bib13","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1056\/NEJM199202203260805","article-title":"Effects of concomitant cisplatin and radiotherapy on inoperable non-small cell lung cancer","volume":"326","author":"Schaake-Koning","year":"1992","journal-title":"N Engl J Med"},{"year":"2004","series-title":"Clinical practice guideline for prevention, diagnosis and management of lung cancer","author":"Australian National Health and Medical Research Council","key":"10.1016\/j.clon.2010.03.007_bib14"},{"key":"10.1016\/j.clon.2010.03.007_bib15","unstructured":"Movsas B, Scott C, Curran W, et\u00a0al. A quality-adjusted time without symptoms or toxicity (QTWiST) analysis of RTOG 9410. Proceedings of ASCO, 2001."},{"year":"2005","series-title":"The diagnosis and treatment of lung cancer","author":"National Institute for Health and Clinical Excellence","key":"10.1016\/j.clon.2010.03.007_bib16"},{"year":"2005","series-title":"Management of patients with lung cancer, no 80","author":"Scottish Intercollegiate Guidelines Network","key":"10.1016\/j.clon.2010.03.007_bib17"},{"key":"10.1016\/j.clon.2010.03.007_bib18","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1378\/chest.07-1379","article-title":"Treatment of non-small cell lung cancer stage IIIA and IIIB","volume":"132","author":"ACCP Guidelines","year":"2007","journal-title":"Chest"},{"key":"10.1016\/j.clon.2010.03.007_bib19","doi-asserted-by":"crossref","first-page":"5910","DOI":"10.1200\/JCO.2005.03.070","article-title":"Randomized phase III trial of sequential chemoradiotherapy compared with concurrent chemoradiotherapy in locally advanced non-small cell lung cancer: groupe Lyon-Saint-Etienne d'oncologie thoracique groupe francais de pneumocancerologie NPC 95-01","volume":"23","author":"Fournel","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clon.2010.03.007_bib20","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.lungcan.2004.03.004","article-title":"Concurrent versus sequential chemoradiotherapy with cisplatin and vinorelbine in locally advanced non-small cell lung cancer; a randomized study","volume":"46","author":"Zatloukal","year":"2004","journal-title":"Lung Cancer"},{"key":"10.1016\/j.clon.2010.03.007_bib21","first-page":"200","article-title":"Evaluation of efficacy of combined chemoradiotherapy in locoregional advanced, inoperable non-small cell lung cancer (clinical randomized trial)","volume":"55","author":"Reinfuss","year":"2005","journal-title":"Nowotwory"},{"key":"10.1016\/j.clon.2010.03.007_bib22","doi-asserted-by":"crossref","first-page":"5883","DOI":"10.1200\/JCO.2005.55.405","article-title":"Combined chemoradiotherapy regimens of paclitaxel and carboplatin for locally advanced non-small cell lung cancer: a randomized phase II locally advanced multimodality protocol","volume":"23","author":"Belani","year":"2005","journal-title":"J Clin Oncol"},{"issue":"2","key":"10.1016\/j.clon.2010.03.007_bib23","doi-asserted-by":"crossref","first-page":"47","DOI":"10.4103\/0973-1482.25849","article-title":"A prospective randomized study of radiotherapy, sequential chemoradiotherapy and concomitant chemoradiotherapy in unresectable non-small cell lung cancer","volume":"2","author":"Dasgupta","year":"2006","journal-title":"J Cancer Res Ther"},{"issue":"27","key":"10.1016\/j.clon.2010.03.007_bib24","doi-asserted-by":"crossref","first-page":"4397","DOI":"10.1200\/JCO.2005.05.4163","article-title":"Simultaneous chemoradiotherapy compared with radiotherapy alone after induction chemotherapy in inoperable stage III non-small cell lung cancer: study CTRT99\/97","volume":"24","author":"Huber","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clon.2010.03.007_bib25","doi-asserted-by":"crossref","first-page":"5045","DOI":"10.1158\/1078-0432.CCR-05-9008","article-title":"Concurrent chemoradiotherapy for unresectable stage III non-small cell lung cancer","volume":"11","author":"Vokes","year":"2005","journal-title":"Clin Cancer Res"},{"issue":"1","key":"10.1016\/j.clon.2010.03.007_bib26","first-page":"73","article-title":"Randomized study of concurrent carboplatin, paclitaxel and radiotherapy with or without induction chemotherapy in patients with locally advanced non-small cell lung cancer","volume":"18","author":"Gouda","year":"2006","journal-title":"J Egypt Nat Cancer Inst"},{"issue":"1","key":"10.1016\/j.clon.2010.03.007_bib27","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.ejca.2006.09.005","article-title":"Randomised trial of sequential versus concurrent chemoradiotherapy in patients with inoperable non-small cell lung cancer (EORTC 08972-22973)","volume":"43","author":"Belderbos","year":"2007","journal-title":"Eur J Cancer"},{"issue":"33","key":"10.1016\/j.clon.2010.03.007_bib28","doi-asserted-by":"crossref","first-page":"5281","DOI":"10.1200\/JCO.2007.12.3133","article-title":"Neoadjuvant cisplatin chemotherapy before chemoradiation; a flawed paradigm?","volume":"25","author":"Glynne-Jones","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clon.2010.03.007_bib29","first-page":"163","article-title":"The Norton\u2013Simon hypothesis revisited","volume":"70","author":"Norton","year":"1986","journal-title":"Cancer Treat Rep"},{"issue":"12","key":"10.1016\/j.clon.2010.03.007_bib30","doi-asserted-by":"crossref","first-page":"2184","DOI":"10.1038\/sj.bjc.6601418","article-title":"Accelerated regrowth of non-small cell lung tumours after induction chemotherapy","volume":"89","author":"El Sharouni","year":"2003","journal-title":"Br J Cancer"},{"issue":"3","key":"10.1016\/j.clon.2010.03.007_bib31","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1053\/clon.2000.9139","article-title":"Lung cancer treatment waiting times and tumour growth","volume":"12","author":"O'Rourke","year":"2000","journal-title":"Clin Oncol"},{"key":"10.1016\/j.clon.2010.03.007_bib32","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1080\/09553000310001609224","article-title":"Proliferation and micomilieu during fractionated irradiation of human FaDu squamous cell carcinoma in nude mice","volume":"79","author":"Petersen","year":"2003","journal-title":"Int J Radiat Biol"},{"key":"10.1016\/j.clon.2010.03.007_bib33","doi-asserted-by":"crossref","first-page":"3760","DOI":"10.1200\/JCO.2005.09.108","article-title":"Phase III study of ECOG: induction chemotherapy followed by either standard thoracic radiotherapy or hyperfractionated accelerated radiotherapy for patients with unresectable stage III NSCLC","volume":"23","author":"Belani","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clon.2010.03.007_bib34","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1007\/s10147-007-0754-y","article-title":"Overview of chemoradiation clinical trials for locally advanced non-small cell lung cancer in Japan","volume":"13","author":"Okamoto","year":"2008","journal-title":"Int J Clin Oncol"},{"issue":"1","key":"10.1016\/j.clon.2010.03.007_bib35","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.lungcan.2004.09.005","article-title":"Patterns of care survey in lung cancer: how well does current US practice with chemotherapy in the non-metastatic setting follow the literature?","volume":"48","author":"Langer","year":"2005","journal-title":"Lung Cancer"},{"issue":"7","key":"10.1016\/j.clon.2010.03.007_bib36","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.clon.2009.04.001","article-title":"Radiochemotherapy for lung cancer in developing countries","volume":"721","author":"Kepka","year":"2009","journal-title":"Clin Oncol"},{"key":"10.1016\/j.clon.2010.03.007_bib37","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.radonc.2006.12.006","article-title":"Lung cancer management in limited resource settings: guidelines for appropriate good care","volume":"82","author":"Macbeth","year":"2007","journal-title":"Radiother Oncol"},{"issue":"35","key":"10.1016\/j.clon.2010.03.007_bib38","doi-asserted-by":"crossref","first-page":"5755","DOI":"10.1200\/JCO.2008.17.7840","article-title":"Phase III study of cisplatin, etoposide and concurrent chest radiation with or without consolidation docetaxel in patients with inoperable stage III NSCLC","volume":"26","author":"Hanna","year":"2008","journal-title":"J Clin Oncol"}],"container-title":["Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0936655510000889?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0936655510000889?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T15:35:14Z","timestamp":1760542514000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0936655510000889"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,6]]},"references-count":38,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2010,6]]}},"alternative-id":["S0936655510000889"],"URL":"https:\/\/doi.org\/10.1016\/j.clon.2010.03.007","relation":{},"ISSN":["0936-6555"],"issn-type":[{"type":"print","value":"0936-6555"}],"subject":[],"published":{"date-parts":[[2010,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Is Concurrent Chemoradiation the Standard of Care for Locally Advanced Non-small Cell Lung Cancer? A Review of Guidelines and Evidence","name":"articletitle","label":"Article Title"},{"value":"Clinical Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clon.2010.03.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 The Royal College of Radiologists. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}